DUBLIN--(BUSINESS WIRE)--ICON (NASDAQ: ICLR)(ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting, a leader in the provision of clinical drug development services in China, today announced that they have signed an alliance agreement.
